Our study showed that LDHA, MRS2, and SLC16A1 were indicators of poor survival, while LDHB and SLC25A12 were indicators of favorable prognosis, suggesting that lactate metabolism is dysregulated in glioma and this dysregulated expression is closely related to tumor progression. Here, SLC16A1 is linked to neoplasm.